{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:51Z","timestamp":1787163891420,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"S17","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2105-13-s17-s5","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T06:15:54Z","timestamp":1355379354000},"source":"Crossref","is-referenced-by-count":32,"title":["Multiple virtual screening approaches for finding new Hepatitis c virus RNA-dependent RNA polymerase inhibitors: Structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors"],"prefix":"10.1186","volume":"13","author":[{"given":"Mahmoud","family":"ElHefnawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"ElGamacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"issue":"10","key":"5469_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd2130","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S: Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nature reviews Drug discovery. 2006, 5 (10): 835-844. 10.1038\/nrd2130.","journal-title":"Nature reviews Drug discovery"},{"issue":"5","key":"5469_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11095-010-0065-2","volume":"27","author":"XH Ma","year":"2010","unstructured":"Ma XH, Shi Z, Tan C, Jiang Y, Go ML, Low BC, Chen YZ: In-silico approaches to multi-target drug discovery: computer aided multi-target drug design, multi-target virtual screening. Pharmaceutical research. 2010, 27 (5): 739-749. 10.1007\/s11095-010-0065-2.","journal-title":"Pharmaceutical research"},{"issue":"3","key":"5469_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1517\/14656560802694481","volume":"10","author":"K Neukam","year":"2009","unstructured":"Neukam K, Macias J, Mira JA, Pineda JA: A review of current anti-HCV treatment regimens and possible future strategies. Expert Opin Pharmacother. 2009, 10 (3): 417-433. 10.1517\/14656560802694481.","journal-title":"Expert Opin Pharmacother"},{"key":"5469_CR4","doi-asserted-by":"crossref","unstructured":"Irshad M: Retracted: Genetic diversity in hepatitis C virus (HCV): a brief review. Rev Med Virol. 2008, 19 (3):","DOI":"10.1002\/rmv.603"},{"issue":"6","key":"5469_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/08830180802432178","volume":"27","author":"M Irshad","year":"2008","unstructured":"Irshad M, Khushboo I, Singh S: Hepatitis C virus (HCV): a review of immunological aspects. Int Rev Immunol. 2008, 27 (6): 497-517. 10.1080\/08830180802432178.","journal-title":"Int Rev Immunol"},{"key":"5469_CR6","doi-asserted-by":"crossref","unstructured":"Mac Nicholas R, Norris S: Review article: optimizing SVR and management of the haematological side effects of peginterferon\/ribavirin antiviral therapy for HCV - the role of epoetin, G-CSF and novel agents. Aliment Pharmacol Ther. 31 (9): 929-937.","DOI":"10.1111\/j.1365-2036.2010.04269.x"},{"issue":"3","key":"5469_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jhep.2008.10.029","volume":"50","author":"SI Kim","year":"2009","unstructured":"Kim SI, Shin D, Lee H, Ahn BY, Yoon Y, Kim M: Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes. J Hepatol. 2009, 50 (3): 479-488. 10.1016\/j.jhep.2008.10.029.","journal-title":"J Hepatol"},{"issue":"3","key":"5469_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1128\/AAC.00939-08","volume":"53","author":"L Coelmont","year":"2009","unstructured":"Coelmont L, Kaptein S, Paeshuyse J, Vliegen I, Dumont JM, Vuagniaux G, Neyts J: Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors. Antimicrob Agents Chemother. 2009, 53 (3): 967-976. 10.1128\/AAC.00939-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5469_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.coph.2009.08.008","volume":"9","author":"T Shimakami","year":"2009","unstructured":"Shimakami T, Lanford RE, Lemon SM: Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities. Curr Opin Pharmacol. 2009, 9 (5): 537-544. 10.1016\/j.coph.2009.08.008.","journal-title":"Curr Opin Pharmacol"},{"issue":"32","key":"5469_CR10","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.2174\/092986710793205471","volume":"17","author":"RRCJ Deore","year":"2010","unstructured":"Deore RRCJ: NS5B RNA dependent RNA polymerase inhibitors: the promising approach to treat hepatitis C virus infections. Curr Med Chem. 2010, 17 (32): 3806-3826. 10.2174\/092986710793205471.","journal-title":"Curr Med Chem"},{"issue":"20","key":"5469_CR11","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1021\/jm0504454","volume":"48","author":"R Di Santo","year":"2005","unstructured":"Di Santo R, Fermeglia M, Ferrone M, Paneni MS, Costi R, Artico M, Roux A, Gabriele M, Tardif KD, Siddiqui A: Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors. J Med Chem. 2005, 48 (20): 6304-6314. 10.1021\/jm0504454.","journal-title":"J Med Chem"},{"issue":"12","key":"5469_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.2174\/138955708786141061","volume":"8","author":"E Tramontano","year":"2008","unstructured":"Tramontano E: The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds. Mini Rev Med Chem. 2008, 8 (12): 1298-1310. 10.2174\/138955708786141061.","journal-title":"Mini Rev Med Chem"},{"key":"5469_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess B, Kutzner C, van der Spoel D, Lindahl E, Comput JCT: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput. 2008, 4: 435-447. 10.1021\/ct700301q.","journal-title":"J Chem Theory Comput"},{"issue":"14","key":"5469_CR14","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1021\/jm9005548","volume":"52","author":"K Vandyck","year":"2009","unstructured":"Vandyck K, Cummings MD, Nyanguile O, Boutton CW, Vendeville S, McGowan D, Devogelaere B, Amssoms K, Last S, Rombauts K: Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase. J Med Chem. 2009, 52 (14): 4099-4102. 10.1021\/jm9005548.","journal-title":"J Med Chem"},{"issue":"4","key":"5469_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/ci700398h","volume":"48","author":"CR Corbeil","year":"2008","unstructured":"Corbeil CR, Englebienne P, Yannopoulos CG, Chan L, Das SK, Bilimoria D, L'Heureux L, Moitessier N: Docking ligands into flexible and solvated macromolecules. 2. Development and application of fitted 1.5 to the virtual screening of potential HCV polymerase inhibitors. J Chem Inf Model. 2008, 48 (4): 902-909. 10.1021\/ci700398h.","journal-title":"J Chem Inf Model"},{"issue":"12","key":"5469_CR16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nrd2424","volume":"6","author":"E De Clercq","year":"2007","unstructured":"De Clercq E: The design of drugs for HIV and HCV. Nat Rev Drug Discov. 2007, 6 (12): 1001-1018. 10.1038\/nrd2424.","journal-title":"Nat Rev Drug Discov"},{"key":"5469_CR17","volume-title":"Medicinal Chemistry Research","author":"AH Mahmoud","year":"2012","unstructured":"Mahmoud AH, Elsayed MSA, ElHefnawi M: Structure-based predictive model for some benzimidazole inhibitors of hepatitis C virus NS5B polymerase. Medicinal Chemistry Research. 2012, 10.1007\/s00044-012-0186-8. [ http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs00044-012-0186-8 ]"},{"issue":"27","key":"5469_CR18","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1021\/jm040134d","volume":"47","author":"PL Beaulieu","year":"2004","unstructured":"Beaulieu PL, Bousquet Y, Gauthier J, Gillard J, Marquis M, McKercher G, Pellerin C, Valois S, Kukolj G: Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells. J Med Chem. 2004, 47 (27): 6884-6892. 10.1021\/jm040134d.","journal-title":"J Med Chem"},{"issue":"23","key":"5469_CR19","doi-asserted-by":"publisher","first-page":"15517","DOI":"10.1074\/jbc.M808889200","volume":"284","author":"JQ Hang","year":"2009","unstructured":"Hang JQ, Yang Y, Harris SF, Leveque V, Whittington HJ, Rajyaguru S, Ao-Ieong G, McCown MF, Wong A, Giannetti AM: Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus. J Biol Chem. 2009, 284 (23): 15517-15529. 10.1074\/jbc.M808889200.","journal-title":"J Biol Chem"},{"issue":"7","key":"5469_CR20","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.bmcl.2010.02.054","volume":"20","author":"CC Cheng","year":"2010","unstructured":"Cheng CC, Shipps GW, Yang Z, Kawahata N, Lesburg CA, Duca JS, Bandouveres J, Bracken JD, Jiang CK, Agrawal S: Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides. Bioorg Med Chem Lett. 2010, 20 (7): 2119-2124. 10.1016\/j.bmcl.2010.02.054.","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"5469_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jcv.2005.03.005","volume":"34","author":"A Savarino","year":"2005","unstructured":"Savarino A: Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza. J Clin Virol. 2005, 34 (3): 170-178. 10.1016\/j.jcv.2005.03.005.","journal-title":"J Clin Virol"},{"issue":"8","key":"5469_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1086\/428781","volume":"191","author":"A Savarino","year":"2005","unstructured":"Savarino A, Cauda R, Cassone A: Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors. J Infect Dis. 2005, 191 (8): 1381-1382. 10.1086\/428781. author reply 1382-1383","journal-title":"J Infect Dis"},{"issue":"7270","key":"5469_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"MJ Keiser","year":"2009","unstructured":"Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB: Predicting new molecular targets for known drugs. Nature. 2009, 462 (7270): 175-181. 10.1038\/nature08506.","journal-title":"Nature"},{"issue":"4","key":"5469_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/bib\/bbr013","volume":"12","author":"JT Dudley","year":"2011","unstructured":"Dudley JT, Deshpande T, Butte AJ: Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform. 2011, 12 (4): 303-311. 10.1093\/bib\/bbr013.","journal-title":"Brief Bioinform"},{"issue":"3","key":"5469_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00126334-200403010-00002","volume":"35","author":"A Savarino","year":"2004","unstructured":"Savarino A, Lucia MB, Rastrelli E, Rutella S, Golotta C, Morra E, Tamburrini E, Perno CF, Boelaert JR, Sperber K: Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J Acquir Immune Defic Syndr. 2004, 35 (3): 223-232. 10.1097\/00126334-200403010-00002.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"5469_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","volume":"6","author":"A Savarino","year":"2006","unstructured":"Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A: New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006, 6 (2): 67-69. 10.1016\/S1473-3099(06)70361-9.","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"5469_CR27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2174\/092986708784638906","volume":"15","author":"H Cao","year":"2008","unstructured":"Cao H, Cao R, Zhang H, Zheng X, Gao D: Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies. Curr Med Chem. 2008, 15 (15): 1462-1477. 10.2174\/092986708784638906.","journal-title":"Curr Med Chem"},{"key":"5469_CR28","doi-asserted-by":"crossref","unstructured":"Structure-based design of hepatitis C virus inhibitors. 2003, 10 (6): 405-412.","DOI":"10.1046\/j.1365-2893.2003.00443.x"},{"issue":"19","key":"5469_CR29","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1016\/j.bmcl.2009.08.022","volume":"19","author":"J de Vicente","year":"2009","unstructured":"de Vicente J, Hendricks RT, Smith DB, Fell JB, Fischer J, Spencer SR, Stengel PJ, Mohr P, Robinson JE, Blake JF: Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides. Bioorg Med Chem Lett. 2009, 19 (19): 5652-5656. 10.1016\/j.bmcl.2009.08.022.","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"5469_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1747-0285.2008.00730.x","volume":"72","author":"J Kim","year":"2008","unstructured":"Kim J, Kim KS, Kim DE, Chong Y: Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening. Chem Biol Drug Des. 2008, 72 (6): 585-591. 10.1111\/j.1747-0285.2008.00730.x.","journal-title":"Chem Biol Drug Des"},{"key":"5469_CR31","doi-asserted-by":"crossref","unstructured":"Musmuca I, Caroli A, Mai A, Kaushik-Basu N, Arora P, Ragno R: Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors. J Chem Inf Model. 50 (4): 662-676.","DOI":"10.1021\/ci9004749"},{"issue":"8","key":"5469_CR32","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.bmc.2009.03.024","volume":"17","author":"K Ryu","year":"2009","unstructured":"Ryu K, Kim ND, Choi SI, Han CK, Yoon JH, No KT, Kim KH, Seong BL: Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation. Bioorg Med Chem. 2009, 17 (8): 2975-2982. 10.1016\/j.bmc.2009.03.024.","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"5469_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/bib\/bbp023","volume":"10","author":"CM Song","year":"2009","unstructured":"Song CM, Lim SJ, Tong JC: Recent advances in computer-aided drug design. Brief Bioinform. 2009, 10 (5): 579-591. 10.1093\/bib\/bbp023.","journal-title":"Brief Bioinform"},{"issue":"suppl 1","key":"5469_CR34","doi-asserted-by":"publisher","first-page":"D198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK: BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research. 2007, 35 (suppl 1): D198-D201.","journal-title":"Nucleic Acids Research"},{"issue":"15","key":"5469_CR35","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1021\/jm060269e","volume":"49","author":"S Hirashima","year":"2006","unstructured":"Hirashima S, Suzuki T, Ishida T, Noji S, Yata S, Ando I, Komatsu M, Ikeda S, Hashimoto H: Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109. Journal of Medicinal Chemistry. 2006, 49 (15): 4721-4736. 10.1021\/jm060269e.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"7","key":"5469_CR36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/jcc.540130714","volume":"13","author":"A Frank","year":"1992","unstructured":"Frank A, Momany RR: Validation of the general purpose QUANTA\u00ae 3.2\/CHARMm\u00ae force field\u2020. Computational Chemistry. 1992, 13 (7): 888-900. 10.1002\/jcc.540130714.","journal-title":"Computational Chemistry"},{"issue":"24","key":"5469_CR37","first-page":"9","volume":"116","author":"MS Lee","year":"2002","unstructured":"Lee MS, Salsbury FR, Brooks CL: Novel generalized Born methods. J Chem Phys. 2002, 116 (24): 9.","journal-title":"J Chem Phys"},{"issue":"5","key":"5469_CR38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1021\/jm8014537","volume":"52","author":"H Li","year":"2009","unstructured":"Li H, Tatlock J, Linton A, Gonzalez J, Jewell T, Patel L, Ludlum S, Drowns M, Rahavendran SV, Skor H: Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-on e (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. J Med Chem. 2009, 52 (5): 1255-1258. 10.1021\/jm8014537.","journal-title":"J Med Chem"},{"issue":"3","key":"5469_CR39","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/ci000150t","volume":"41","author":"JH Voigt","year":"2001","unstructured":"Voigt JH, Bienfait B, Wang S, Nicklaus MC: Comparison of the NCI open database with seven large chemical structural databases. J Chem Inf Comput Sci. 2001, 41 (3): 702-712. 10.1021\/ci000150t.","journal-title":"J Chem Inf Comput Sci"},{"issue":"Pt 8","key":"5469_CR40","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf AW, van Aalten DM: PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004, 60 (Pt 8): 1355-1363.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"5469_CR41","doi-asserted-by":"crossref","unstructured":"Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39 (Database): D1035-1041.","DOI":"10.1093\/nar\/gkq1126"},{"issue":"1","key":"5469_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK: ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005, 45 (1): 177-182. 10.1021\/ci049714+.","journal-title":"J Chem Inf Model"},{"issue":"43","key":"5469_CR43","doi-asserted-by":"publisher","first-page":"15204","DOI":"10.1021\/ja101358s","volume":"132","author":"SR LaPlante","year":"2010","unstructured":"LaPlante SR, Gillard JR, Jakalian A, Aubry N, Coulombe R, Brochu C, Tsantrizos YS, Poirier M, Kukolj G, Beaulieu PL: Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B. Journal of the American Chemical Society. 2010, 132 (43): 15204-15212. 10.1021\/ja101358s.","journal-title":"Journal of the American Chemical Society"},{"issue":"5","key":"5469_CR44","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1021\/jm061207r","volume":"50","author":"MJ Slater","year":"2007","unstructured":"Slater MJ, Amphlett EM, Andrews DM, Bravi G, Burton G, Cheasty AG, Corfield JA, Ellis MR, Fenwick RH, Fernandes S: Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate. J Med Chem. 2007, 50 (5): 897-900. 10.1021\/jm061207r.","journal-title":"J Med Chem"},{"issue":"14","key":"5469_CR45","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1016\/j.bmcl.2008.05.083","volume":"18","author":"SH Kim","year":"2008","unstructured":"Kim SH, Tran MT, Ruebsam F, Xiang AX, Ayida B, McGuire H, Ellis D, Blazel J, Tran CV, Murphy DE: Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem Lett. 2008, 18 (14): 4181-4185. 10.1016\/j.bmcl.2008.05.083.","journal-title":"Bioorg Med Chem Lett"},{"key":"5469_CR46","unstructured":"[ http:\/\/www.cs.waikato.ac.nz\/ml\/weka\/ ]"},{"issue":"47","key":"5469_CR47","doi-asserted-by":"publisher","first-page":"39260","DOI":"10.1074\/jbc.M506407200","volume":"280","author":"G Kukolj","year":"2005","unstructured":"Kukolj G, McGibbon GA, McKercher G, Marquis M, Lefebvre S, Thauvette L, Gauthier J, Goulet S, Poupart MA, Beaulieu PL: Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase. J Biol Chem. 2005, 280 (47): 39260-39267. 10.1074\/jbc.M506407200.","journal-title":"J Biol Chem"},{"issue":"11","key":"5469_CR48","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1128\/AAC.47.11.3525-3530.2003","volume":"47","author":"TT Nguyen","year":"2003","unstructured":"Nguyen TT, Gates AT, Gutshall LL, Johnston VK, Gu B, Duffy KJ, Sarisky RT: Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor. Antimicrob Agents Chemother. 2003, 47 (11): 3525-3530. 10.1128\/AAC.47.11.3525-3530.2003.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"5469_CR49","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1128\/AAC.49.10.4305-4314.2005","volume":"49","author":"H Mo","year":"2005","unstructured":"Mo H, Lu L, Pilot-Matias T, Pithawalla R, Mondal R, Masse S, Dekhtyar T, Ng T, Koev G, Stoll V: Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro. Antimicrob Agents Chemother. 2005, 49 (10): 4305-4314. 10.1128\/AAC.49.10.4305-4314.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"5469_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00894-009-0519-9","volume":"16","author":"Herdewijn TLMFP","year":"2010","unstructured":"Herdewijn TLMFP: Insight into ligand selectivity in HCV NS5B polymerase: molecular dynamics simulations, free energy decomposition and docking. molecular modeling. 2010, 16: 49-59. 10.1007\/s00894-009-0519-9.","journal-title":"molecular modeling"},{"issue":"12","key":"5469_CR51","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1128\/JVI.02628-05","volume":"80","author":"S Le Pogam","year":"2006","unstructured":"Le Pogam S, Kang H, Harris SF, Leveque V, Giannetti AM, Ali S, Jiang WR, Rajyaguru S, Tavares G, Oshiro C: Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus. J Virol. 2006, 80 (12): 6146-6154. 10.1128\/JVI.02628-05.","journal-title":"J Virol"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-13-S17-S5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2105-13-S17-S5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-13-S17-S5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T04:34:40Z","timestamp":1714710880000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-13-S17-S5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":51,"journal-issue":{"issue":"S17","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["5469"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-13-s17-s5","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"S5"}}